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Basidiomycete yeasta b s t r a c t
Fungal infections are often difﬁcult to treat due to the inherent similarities between fungal and animal
cells and the resulting host toxicity from many antifungal compounds. Cryptococcus neoformans is an
opportunistic fungal pathogen of humans that causes life-threatening disease, primarily in immunocom-
promised patients. Since antifungal therapy for this microorganism is limited, many investigators have
explored novel drug targets aim at virulence factors, such as the ability to grow at mammalian physio-
logical temperature (37 C). To address this issue, we used the Agrobacterium tumefaciens gene delivery
system to create a random insertion mutagenesis library that was screened for altered growth at elevated
temperatures. Among several mutants unable to grow at 37 C, we explored one bearing an interruption
in the URA4 gene. This gene encodes dihydroorotase (DHOase) that is involved in the de novo synthesis of
pyrimidine ribonucleotides. Loss of the C. neoformans Ura4 protein, by targeted gene interruption,
resulted in an expected uracil/uridine auxotrophy and an unexpected high temperature growth defect.
In addition, the ura4mutant displayed phenotypic defects in other prominent virulence factors (melanin,
capsule and phospholipase) and reduced stress response compared to wild type and reconstituted strains.
Accordingly, this mutant had a decreased survival rate in macrophages and attenuated virulence in a
murine model of cryptococcal infection. Quantitative PCR analysis suggests that this biosynthetic path-
way is induced during the transition from 30 C to 37 C, and that transcriptional regulation of de novo
and salvage pyrimidine pathway are under the control of the Ura4 protein.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Cryptococcus neoformans is a pathogenic fungus with a world-
wide distribution. This yeast is found in the environment on rotting
wood, and it is often associated with avian excreta. It can cause
life-threatening respiratory and neurological infections, especially
in immunocompromised patient populations. In fact, recent sur-
veys estimate greater than 500,000 deaths due to C. neoformans
each year, mainly in patients with AIDS and other immune com-
promising conditions (Park et al., 2009). The immunocompromised
population has increased world-wide due to many factors includ-
ing the AIDS pandemic and growing numbers of transplantpatients. Together, these factors have turned this yeast into a major
pathogen (Mitchell and Perfect, 1995; Singh and Husain, 2000).
Options for antifungal therapies for cryptococcosis are limited.
Among the common agents used for this infection are polyenes
(amphotericin B-based drugs), antimetabolites (ﬂucytosine), and
azoles (Perfect et al., 2010). However, drug toxicity and antifungal
resistance remain important issues in the treatment of all fungal
infections (Rex et al., 2001; Paiva and Pereira, 2013). To address
potential novel strategies for antifungal therapy, we and others
have studied virulence-associated phenotypes that allow C. neofor-
mans to survive within the infected host and to cause disease. These
factors include polysaccharide capsule, melanin, phospholipase,
and growth at 37 C (Heitman et al., 2006; Brown et al., 2007; Li
andMody, 2010; Lam et al., 2013). The ability of this fungus to grow
at human physiological temperature is controlled by several cellu-
lar factors, including the effectors of the calcineurin and Ras signal
transduction pathways (Odom et al., 1997; Alspaugh et al., 2000;
Kozubowski et al., 2009). To identify additional elements that are
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mutagenesis strategy mediated by Agrobacterium tumefaciens to
generate mutants of C. neoformans unable to grow at 37 C
(Idnurm et al., 2004; McClelland et al., 2005). Using this method,
we identiﬁed temperature-sensitive strains containing mutations;
one of these was defective in pyrimidine biosynthesis.
The de novo synthesis of uracil monophosphate (UMP) is essen-
tial for the synthesis of nucleic acids, and it is a commonbiosynthetic
pathway for all organisms. Some cells can also make UMP using
pyrimidine (Norager et al., 2002). In addition to basic cell growth,
many organisms, including pathogenic parasites, require efﬁcient
pyrimidine biosynthesis for rapid cell proliferation and adaptation
to cell stress (Fairbanks et al., 1995; Fox and Bzik, 2010; Ali et al.,
2013; Hegewald et al., 2013; Ong et al., 2013). In S. cerevisiae, tran-
scription of genes linked to the uracil biosynthesis pathway can
increase three to eight times the yeast cells are subjected to pyrim-
idine limitation (Roy et al., 1990). The enzyme dihydroorotate
dehydrogenase (DHOase-URA1) converts dihydroorotate into
orotate, and DHOase inhibitors have been successfully tested as
antiproliferative agents in neoplastic growth, as suppressors of
immunological responses (Chen et al., 1992; Greene et al., 1995;
Liu et al., 2000; Khutornenko et al., 2010), and also as inhibitors of
the growth of Toxoplasma gondii (Hegewald et al., 2013). In the
basidiomycete Ustilago maydis, the pyr4 gene encodes dihydrooro-
tate dehydrogenase, and its absence results in loss of pathogenicity
and uracil auxotrophy (Banuett, 1995; Bölker, 2001; Zameitat et al.,
2007). Previous work by Morrow et al. (2012) showed that de novo
synthesis of purine derivatives such as GTP is also important for
virulence in C. neoformans.
C. neoformans encodes genes for pyrimidine de novo (URA1
through URA6) and salvage (URH1, URK1 and CDD1) pathways
(Fig. 1A andB, respectively), suggesting this yeast canuse both strat-
egies to obtain this essential nutrient. One pyrimidine biosyntheticFig. 1. Representation of the pyrimidine ribonucleotide de novo biosynthetic (Agene that has been previously characterized in C. neoformans is
URA5, and this has been primarily used as selectable marker for
transformation (Edman and Kwon-Chung, 1990; Kwon-Chung
et al., 1992; Varma et al., 1992). However the virulence phenotypes
associated with the ura5 mutation have not been extensively
characterized. In this paper we studied the role of the URA4 gene
in C. neoformans, the impact of its interruption on virulence factors
and survival in vitro and in vivo. Also, the relationship between the
pyrimidine de novo and salvage pathways and high temperature
growth was established by transcription analysis. Our results
showed that these pathways are not only important for the high
temperature growth trait but also for the expression of several
virulence factors, as well as efﬁcient responses to cell stresses.2. Material and methods
2.1. Strains, media and reagents
All wild-type, deletion and reconstituted strains were generated
in the C. neoformans var. grubii KN99a background (MATalpha)
donated by Dr Joseph Heitman. The ura5 mutans were obtained
after selection of C. neoformans var. grubii strains baring spontane-
ous mutation of the URA5 gene after incubation on YPD medium
containing 5-FOA (5-ﬂuoroorotic acid, 10 lg/mL). Oligonucleotide
primers are presented in Tables 1 and 2. The media used were stan-
dard YPD medium (1% yeast extract, 2% peptone and 2% dextrose,
2% agar), synthetic medium (6.7 g/l Sigma Yeast Nitrogen Base
with amino acids and ammonium sulfate, 2% dextrose, 2% agar)
with or without addition of 20 lM uracil (Sigma). Geneticin (Invit-
rogen) and Hygromycin (Invitrogen) were added to the selection
medium for transformation at 200 lg/mL ﬁnal concentration, as
indicated.) and salvage (B) pathways (adapted from http://www.yeastgenome.org/).
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C. neoformans genomic DNA extraction was performed as pub-
lished (Pitkin et al., 1996). General molecular biology manipula-
tions were performed according to Sambrook et al. (1989).
Southern blots were performed using Roche PCR DIG Probe
Synthesis kit, DIG Wash and blot kit, CDP-star ready according to
the manufacturer’s instructions.
2.3. A. tumefaciens random insertion mutagenesis
The C. neoformans mutant collection was created according to
the method described by Idnurm et al. (2004). Brieﬂy, Agrobacte-
rium mediated-transformation was achieved by co-culture of the
C. neoformans strain KN99awith A. tumefaciens LBA4404 strain har-
boring the plasmid pPZP-Hyg2 or pPZP-Neo1 (Walton et al, 2006,
donated by Heitman) and induced with 100 lM of acetosyringone.
Co-culture was conducted for 48 h and aliquots were plated on YPD
medium supplemented with 200 lg/mL Geneticin or 200 lg/mL
Hygromycin, and cefotaxime (100 lg/mL) to kill Agrobacterium.
After 48–72 h, antibiotic resistant colonies were transferred to
YPD medium supplemented with the appropriate antibiotic and
incubated at 30 C and 37 C. Strains that grew at 30 C but that
failed to grow at 37 C were chosen for further analysis. The select-
able marker insertion site was identiﬁed by inverse PCRmethods as
previously described (Idnurm et al., 2004). Brieﬂy, we extracted
genomic DNA from these strains, and digested with either HindIII
or EcoRI, (Fermentas). The digested DNA was puriﬁed through a
Qiagen column (Qiaquick PCR Puriﬁcation Kit), and ligated to itself
with T4 DNA ligase. PCR was performed using primers directed
against selectable marker sequences (primers MAV30 and
MAV32, MAV31 and MAV33 (Table 1). Gel puriﬁed PCR products
obtained by inverse PCR were sequenced and compared to the
Broad Institute C. neoformans strain H99 genome database to deter-
mine the position of the T-DNA insertion into the genome.
2.4. Gene deletion and reconstitution, and C. neoformans
transformation
Independent ura4mutants were generated by biolistic transfor-
mation and homologous recombination. The URA4 coding region
was partially replaced with the Geneticin resistance cassette con-
taining the NeoR gene under control of the actin ACT1 promoter
and TRP1 terminator (Walton et al., 2005). In vitro construction of
the deletion cassette was performed using PCR overlap extension
(Davidson et al., 2002) using the following primers (left arm: prim-
ers MAV067 and MAV097, right arm: MAV098 and MAV072, and
Geneticin resistance gene: MAV099 and MAV070) described in
Table 1. The cassette was introduced into C. neoformans KN99a
by the biolistic method as described (Toffaletti et al., 1993), and
transformants were screened for the ura4 mutation by PCR and
Southern blots. The ura4 + URA4 reconstituted strain was gener-
ated by introducing the wild-type URA4 allele into the ura4mutant
strain by the biolistic method. Brieﬂy, the reconstituted strain was
selected on synthetic media (YNB) without uracil, and this strain
also became sensitive to Geneticin. As a control, the same culture
of mutant cells was subject to bombardment with gold particles
without DNA and the selection on YNB without uracil did not yield
any colony. The primers used to generate the deletion and recon-
stitution strains are described in Table 1.
2.5. High temperature growth ability, melanin and capsule production
assay
Thermotolerancewas evaluated onboth rich (YPD) and synthetic
media (YNB) at 30 C and 37 C. To assess melanin production,overnight cultureswere incubated in YPDmedium, spotted onNiger
seed agar plates (75 g/l Niger bird seed, 0.1% dextrose, 2% agar, with
20 lM uracil), and incubated at 30 C for up to 96 h. Capsule was
induced by inoculating fresh cells of each strain in CO2-independent
medium (Gibco, Cat 18C45-088) with and without 20 lM uracil at
30 C at 150 rpm rotation (O’Meara et al., 2013). After 24 h incuba-
tion, cellswere stainedwithBactiDrop India Ink (Remel) anddirectly
observed by light microscopy. Alternatively, induced cells were
washed in 1 PBS, resuspended in PBS and 1% Bovine Serum
Albumin, incubated with 1 lL of mAb 18B7 (Casadevall and
Perfect, 1998) under gentle agitation for 1 h at room temperature.
Cells were washed in PBS + 1% BSA and incubated with 1 lL of
ﬂuorescent Alexa Fluor 594 Goat Anti-Mouse IgG (Life Technolo-
gies) for 1 h at room temperature with gentle rotation. After 2
washes in PBS, cells were observed by ﬂuorescent microscopy with
red ﬁlter (Texas Red). Differential interference microscopy (DIC),
bright ﬁeld, and ﬂuorescent images were obtainedwith a Zeiss Axio
Imager.A1 ﬂuorescent microscope and AxioCamMR digital camera.
Also, we have cultured the strains on CO2-independent medium
supplemented with uracil and uridine (20 lg/mL) up to 72 h at
30 C and 37 C.
2.6. Multistress sensitivity assay
Osmotic, ionic and cell wall stress were assessed by spotting
cells onto YPD plates supplemented with 0.75 M KCl, 0.75 M NaCl,
0.5% Congo Red, or pH 8.0. All cultures were incubated at 30 C.
2.7. Minimal inhibitory concentration assay
Sensitivity to antifungal drugs was determined for mutant,
reconstituted and wild type strains by standard minimal inhibitory
concentration (MIC) assays according to Clinical and Laboratory
Standards Institute (CLSI M27-A2) protocols with modiﬁcations.
Brieﬂy, fresh cultures were diluted and 100 cells were inoculated
in YNB plus 20 lM of uracil. The concentration of ﬂuconazole ran-
ged from 16 to 0.0625 lg/mL, and that of amphotericin B from 1 to
0.03 lg/mL. A control with cells and without drugs was included,
and a blank containing only medium was also applied in the assay.
MIC80 was deﬁned as the drug concentration in which growth was
at least 80% inhibited compared to the drug-free control following
incubation for 72 h at 30 C. Growth was determined by measuring
the turbidity of the cell suspension in a Multiskan Ascent (Lab
System) at 620 and 540 nm. After absorbance reading, the cells
were stained with 0.001% vital dye Rezasurine (Sigma) for 1 h at
30 C and 150 rpms. All experiments were performed in triplicate
for ﬂuconazole and amphotericin B, and two biological replicates
were applied.
2.8. Transcriptional analysis by real time PCR
Total RNA for transcriptional pattern analysis was obtained from
cells incubated for 2 h in YPD and YNB at 30 C and 37 C. Cells were
harvested, washed three times in PBS, ﬂash frozen on dry ice, and
lyophilized. RNA extraction was performed according to Yang
et al. (2002). cDNA synthesis was performed with RevertAid H
minus First Strand cDNA synthesis kit (Thermo Scientiﬁc) with
Oligo dT and random hexamer primers from 5 lg of total RNA. Real
time PCR ampliﬁcations were made from diluted templates (1:10)
with 800 nM target primers, 300 nM GPD1 (Glyceraldehyde-
3-phosphate dehydrogenase, Varma and Kwon-Chung, 1999) as
internal control primers, and 1X Power SYBR Greenmastermix (Life
Technologies). Quantiﬁcation of the transcript levels was
performed using the DDCT method (Livak and Schmittgen, 2001),
normalizing against GPD1 as previously described by
Vandesompele et al. (2002).
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Macrophage-like J744.A1 cells were used to assay survival of
yeasts within mammalian cells according to the methods of Cox
et al. (2003). In brief, mAb-opsonized (mAb 18B7 antibody
(McFadden and Casadevall, 2004) C. neoformans cells were co-incu-
bated in 96-well tissue culture plates with J774A.1 cells in 200 lL
macrophage medium at a multiplicity of infection (MOI) of 10:1
(1  106 C. neoformans cells/200 lL, and 1  105 J774A.1 cells/
200 lL). The J774A.1 cells were activated by adding LPS and
INF-V one day prior to introducing the fungal cells. After an initial
co-culture for 1 h, the non-internalized fungal cells were removed
by washing 3 times with PBS, and fresh medium was added. After
24 h of incubation, the mammalian cells were disrupted with 0.5%
SDS for 5 min, and the number of viable C. neoformans cells was
determined by quantitative culture. Statistical validation was
calculated for each macrophage co-cultivation experiment, and
CFU counts were compared among strains by one-way ANOVA fol-
lowed by Tukey’s post-test for comparison of pairs. Differences
were considered valid at a 95% conﬁdence interval (p < 0.05).
The phagocytic index was determined as follows: separate
plates containing macrophages where incubated with the three
fungal strains under the same conditions, and after 2 h of phagocy-
tosis, the wells were washed twice with PBS to remove free yeast
cells and stained with a commercial equivalent of Giemsa for fast
processing of microscopic samples (Instant-Prov Quick Haemato-
logical Stain, New Prov Laboratory Products, Brazil) and observed
in an inverted microscope for measurement of the phagocytic
index. This was calculated as the percentage of cells containing
at least one yeast to the total number of cells. For each strain,
900–1200 cells were counted in nine separate ﬁelds.
2.10. In vivo virulence assay
Virulence of the C. neoformans strains was assessed in the mur-
ine inhalation model of cryptococcal infection (Cox et al., 2000).
Brieﬂy, groups of 4- to 6-week-old C57/BL6 mice were anaesthe-
tized with 7.5 lL/g i.p. of a mixture of ketamine (10.25 mg/mL)
and xylazine (0.86 mg/mL). The mice were then infected via nasal
inhalation with the wild-type strain KN99a, mutant (ura4) or
reconstituted (ura4D + URA4) strains. The inoculum (105 cells in a
25 lL per strain) was prepared from cultures which were incu-
bated overnight in YPD at 30 C. Ten mice were infected for each
strain. Mice were examined twice daily and sacriﬁced according
to clinical measures predicting mortality (weight loss >15%, inabil-
ity to access food and water). Survival data were analyzed by the
Kruskal–Wallis test. The ura4-infected mice were sacriﬁced at 40
days post-infection; lungs from two of the surviving mice were
harvested, homogenized, serially diluted, and plated on YPD to
access the number of viable cells in the lungs. These experiments
were performed at Duke University in accordance with institu-
tional guidelines for animal experimentation.
Galleria mellonella killing assay. The infection of G. mellonella by
C. neoformans was performed according to Mylonakis et al. (2005).
This assessment of virulence was performed at a permissive tem-
perature (30 C) for the ura4 mutant strain to assess temperature-
independent aspects of survival in an infected host. Brieﬂy, larvae
with average body weight of 174 mgwere separated in groups with
14 individuals. Each groupwas inoculatedwith 1  105 cells of wild
type (KN99a), ura4 (FGC003) or the reconstituted strain
ura4D + URA4 (FGC003R1) with a 10-ll Hamilton syringe. PBS
(phosphate buffered saline) was used as control. Ampicilin
(20 mg/kg of body weight) was administrated with all inocula to
avoid bacterial contamination. After infection, the G. mellonella lar-
vae were incubated in a glass Petri dish (15 mm diameter) at 30 C,
and survival (as assessed by spontaneous or provoked motion) wasaccessed daily. Observation was completed when the larvae died or
formed cocoons. Statistical analysis between treatment groups was
preformed employing Prism (GraphPad Software, La Jolla, USA). A p
value of <0.05 was considered signiﬁcant by Tukey’s multiple com-
parison test.3. Results
3.1. C. neoformans dihydroorotase activity is required for high
temperature growth
To identify C. neoformans elements involved in high temperature
growth, we used insertional mutagenesis to create a panel of
C. neoformansmutant strains, screening for temperature sensitivity.
Using the wild type strain KN99a as a recipient for mutagenesis, we
identiﬁed 64 mutants unable to grow at 37 C. To deﬁne the sites of
selectable marker insertion, we isolated genomic DNA from each
strain and used inverse PCR to characterize the junction sequences
between the inserted transfer DNA (t-DNA) and the interrupted
C. neoformans DNA sequence. Typically, this method of transconju-
gation results in single, stable insertion mutations in the fungal
genome (Idnurm et al, 2004). One of these strains, mutant G368,
had an insertion present on chromosome I, which truncated a gene
annotated as CNAG_00734 at amino acid residue 159 (Fig. S2).
BLAST search analysis at NCBI and SGD (Saccharomyces Genome
Database) revealed that CNAG_00734 has similarity to the S. cerevi-
siae dihydroorotase (DHO) (EC 3.5.2.3) encoding gene URA4
(YLR420W). DHO catalyzes a step in pyrimidine ribonucleotide bio-
synthetic pathway (Fig. 1A), converting N-carbamoyl-L-aspartate
into L-dihydroorotate by cyclical dehydration (Guyonvarch et al.,
1988). No human homolog of this gene was identiﬁed.
The predicted protein sequence encoded by the C. neoformans
URA4 gene was aligned with orthologous sequences from U. may-
dis, S. cerevisiae (S288c), Candida albicans, and Schizosaccharomyces
pombe. The highest similarity is shared between the two basidio-
mycetes C. neoformans and U. maydis (61.2%), and the remaining
similarities range between 47% and 59%. Moreover, the putative
C. neoformans Ura4 protein has the two conserved signatures
attributed to DHO enzymes (http://prosite.expasy.org/). The ﬁrst
domain spans residues 12–20, including two invariant histidines
at positions 14 and 16. The second conserved domain spans resi-
dues 242–255 and has ﬁve highly conserved amino acids (D244,
A246, P247, H248 and K253). Mehboob et al. (2010) described
the crystal structure of Bacillus anthracis DHO. In this bacterium
there is an active site, which includes a binuclear Zn center, where
the H14 and H16 residues and the D224 and D244 residues all bind
an a-Zinc atom, and two distant histidines and asparagines bind to
a b-Zinc atom.
3.2. C. neoformans URA4 gene deletion and reconstitution
To ensure that the temperature-sensitive phenotype of this
strain was due to the ura4 mutation, we created an independent
ura4 mutant strain in which we replaced 181 base pairs from the
wild type locus, encoding residues 126 to 151, with the neomycin
resistance gene. The ura4 mutation and subsequent reconstitution
were conﬁrmed by Southern blot analysis (Supplemental Fig. S1).
These independently generated strains were used in all subsequent
analyses.
3.3. Uracil auxotrophic mutants are sensitive to high temperature
growth
In order to conﬁrm the high temperature growth sensitivity is
due to absence of a functional dihydroorotase in C. neoformans,
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(KN99a) and reconstituted strain FGC003R1 (ura4D::URA4) were
inoculated on YPD plates and incubated at 30 C and 37 C for
48 h. Fig. 2 shows that wild type and reconstituted strains grow
at the same rate in both temperatures, whereas the ura4 mutant
strain FGC003 is no longer able to grow at 37 C. We explored
whether the URA4 gene itself or the pyrimidine biosynthetic path-
way in general is required for high-temperature growth by testing
two ura5mutants for this phenotype. These strains have mutations
in a distinct component of pyrimidine biosynthesis, and they were
made in related but different strain backgrounds (KN99a and H99,
both serotype A). Similar to the ura4 mutants, both ura5 strains
were unable to grow at 37 C.Fig. 2. High temperature growth and auxotrophic analysis. Wild type (KN99a), ura4::N
original insertional mutant G368 were incubated on the following media at 30 C and 37
amino acids (YNB), with or without addition of uracil (20 lM) or uridine (20 lM); and 5-
inoculated in each spot is: 1  104, 1  103, 1  102, 1  101 and 1 cell.Consistent with its predicted function, mutation of the C. neofor-
mans URA4 gene caused themutant strain to be auxotrophic for ura-
cil, similar to the ura5 mutant strain (Fig. 2). Similar to the wild
type, the ura4 mutant strain FGC003 was inhibited by the addition
of 5-ﬂuoroorotic acid (5-FOA) to the growth medium. In contrast,
the ura5mutant was able to growwell on 5-FOA-containing media,
as expected considering that the two genes are predicated to act in
different steps of the pathway,with the C. neoformansUra5 convert-
ing 5-FOA to ﬂuorodeoxyuridine, which is toxic to cells (Edman and
Kwon-Chung, 1990; Kwon-Chung et al., 1992).
Taken together these observations suggest that: (i) the URA4
gene (CNAG_00734) is part of the pyrimidine biosynthetic pathway
encoding DHO in C. neoformans and (ii) blocking pyrimidineeoR (FGC003), reconstituted strain ura4D + URA4 (FGC003R1), ura5 mutant and the
C for 48 h: YPD; YNB supplemented with 2% glucose, 5 g/l ammonium sulfate, and
FOA (5-ﬂuoroorotic acid) medium (10 mg/mL). From left to right the amount of cells
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serotype A to grow at mammalian physiological temperature.
3.4. The ura4 mutation affects multiple virulence factors in C.
neoformans
Besides high temperature growth, ‘‘classical’’ virulence factors
for C. neoformans include the production of melanin, capsule and
phospholipase B activity. Melanized cells are more resistant to
reactive oxygen intermediates (ROI) and reactive nitrogen inter-
mediates (RNI) than non-melanized cells (Wang and Casadevall,
1994). Strains that do not produce this pigment are reported to
have attenuated virulence in animal models (Kwon-Chung et al.,
1982; Kwon-Chung and Rhodes, 1986). The ura4 mutant strain
produced melanin, however in a delayed fashion. While colonies
of the wild type (KN99a), reconstituted strain (ura4D + URA4)
and ura5 mutant produce melanin within 48 h of incubation
(Fig. 3A), the ura4 strain colonies are pigmented only after 72 h
(data not shown). This was observed regardless of whether the
medium was supplemented with uracil.
Another well-studied virulence factor is the production of a
polysaccharide capsule which allows C. neoformans to evade phago-
cytosis by macrophages (Kozel and Gotschlich, 1982; Chang and
Kwon-Chung, 1994, 1998; Chang et al., 1996). We evaluated this
phenotypic trait by direct observation of India ink staining and light
microscopy, as well as with immunoﬂuorescence. Both methods
reveal a dramatic decrease in capsule production by the ura4
mutant in comparison to the wild type (KN99a) and reconstituted
(FGC003R1) strains (Fig. 3B), regardless of uracil supplementation.
Interestingly, two independent ura5 mutants presented a similar
capsule-poor phenotype as observed for the ura4 mutant strain,
irrespective of uracil addition to the medium (data not shown),
however, addition of uridine (20 lM) reverted this condition for
the ura4 mutant (Fig. S3) [ANOVA, t-Student’s and Scott Knout,
p < 0.05]. At 30 C there was no signiﬁcant variation in the capsular
volume between KN99a, ura4D, or ura4D + URA4. Together, these
data suggest that an intact pyrimidine biosynthesis pathway is
required for the efﬁcient induction of surface capsule expression
Phospholipase B is involved in tissue invasion by breaking down
the host cell membrane leading to cell lysis (Ghannoum, 2000).
Previous studies revealed that the C. neoformans phospholipase B
mutant (plb1) has a slower intracellular growth inside macro-
phages (Cox et al., 2001). Phospholipase B activity can be assessed
by measuring the zone of precipitation (Pz) on egg yolk-containing
media (Price et al., 1982). Nine independent colonies were spotted
for each strain to calculate an average Pz index. Statistical analysis
showed that the Pz index, while not signiﬁcantly different between
the wild type (1.76 ± 0.26) and the ura4 + URA4 reconstituted strain
(1.56 ± 0.32), was signiﬁcantly smaller for the ura4 mutant
(1.17 ± 0.73, p < 0.05), consistent with Ura4-dependent phospholi-
pase B production. Fig. S4 illustrates the capsule production of
these strains. Addition of uracil (20 lM) or uridine (20 lM) in
the medium did not rescue the phospholipase activity for the
mutant.
3.5. URA4 gene is involved in multi-stress resistance
The C. neoformans cell wall is an important organelle which pro-
vides protection from the environment and determines the multi-
ple cell morphologies that this yeast assumes during its
development (reviewed in Casadevall and Perfect, 1998). To assess
the role of Ura4 in cell integrity and stress response, we incubated
the wild type, ura4 mutant and ura4 + URA4 strains on media con-
taining various compounds known to affect cell wall phenotypes.
The ura4 mutant displayed a marked sensitivity to Congo Red
and high salt concentrations (Fig. 4A). Cell wall assembly isimpaired by Congo Red (CR), which interferes with cell morphol-
ogy and mother cell-bud separation in S. cerevisiae (for review
see Kopecká and Gabriel, 1992; Ram and Klis, 2006). Additionally,
resistance to salt stress has been correlated to C. neoformans sur-
vival in vivo, and genes involved and/or regulated by the HOG path-
way must be expressed during osmotic stress (Idnurm et al., 2009;
Ko et al., 2009; Jung et al., 2012).
Another stress that C. neoformans is subject to during the infec-
tion of the host is altered pH. The fungal cells have a preference for
acidic growth conditions, and during infection the mammalian tis-
sues offer a slightly alkaline environment. Therefore, an array of
genes must be transcribed to respond to this new environment
(Casadevall, 2005). We observed that the ura4 mutant has a dra-
matic growth defect at elevated pH compared to wild type and
reconstituted strains (Fig. 4B).3.6. Uracil deﬁciency increases drug susceptibility
Antifungal agents with activity against cryptococcosis act
mainly upon the cell membrane (van der Horst et al., 1997). The
azoles (e.g., ﬂuconazole) interferes with the ergosterol biosynthesis,
whereas the polyenes (e.g., amphotericin B) binds the ergosterol in
the fungal cell membrane leading to leakage of uni- and divalent
cations resulting in cell death (for reviews see Bolard, 1986;
Fromtling, 1988). To assess whether any of these drugs would act
in association with the pyrimidine biosynthesis pathway defect,
we tested them against the wild type, ura4mutant and ura4 + URA4
reconstituted strains. The three strains were equally sensitive to
ﬂuconazole in rich medium (YPD) as well as in synthetic medium
(YNB supplemented with uracil). MIC testing with amphotericin B
demonstrated that the ura4 mutant strain had an increased sensi-
tivity to this drug leading to growth arrest at 0.06 lg/mL, compared
to the MIC for the wild type KN99a of 0.5 lg/mL. The reconstituted
strain (uraD + URA4) demonstrated a higher MIC than the mutant,
though not fully to the level of wild type. We also tested whether
other defects in pyrimidine biosynthesis would result in similar
changes in amphotericin susceptibility, and we noted that the
ura5mutant strain behaved similar to the ura4mutant being inhib-
ited by amphotericin B at 0.06 lg/mL. Banerjee et al. (2014) tested
the susceptibility of C. neoformans var grubii (H99) ura5 mutant
against ﬂuconazole and amphotericin B. They also observed that
mutants with a depleted pyrimidine pathway are more susceptible
to amphotericin B compared to wild type and reconstituted,
whereas ﬂuconazole affected the wild type and mutant equally.
This information suggests that inhibition of the pyrimidine biosyn-
thetic pathway, in association with cell membrane-active agents,
might have a positive impact on the treatment of cryptococcosis.3.7. The URA4 gene is essential for fungal survival within macrophages
All the results described above indicate that the ura4 mutant
strain would not likely succeed in avoiding macrophage phagocy-
tosis and subsequent fungal killing. Therefore, we tested for
intracellular survival in the macrophage lineage J744.A1. When
co-cultured with these murine macrophages, the ura4 mutant
strain did not survive as well as the wild type (KN99a) or reconsti-
tuted (ura4D + URA4) strains. After 24 h of co-incubation with
J774.A1 cells, the ura4 mutant strain demonstrated a marked
decrease in survival (435.3 ± 37.4 CFU/ml) compared to wild type
(735.9 ± 42.3 CFU/ml) or the reconstituted strain (814 ± 82 CFU/
ml) (p < 0.05 for each comparison). The ura5 mutant similarly does
not survive well inside the macrophage (214.5 ± 74.2 CFU/ml). The
altered survival was not attributable to varying rates of engulfment
since the phagocytosis index was identical among these strains
(data not shown). Taken together, these results link defects in
Fig. 3. Melanin and capsule production in ura4 mutant. (A) 1  105 cells were spotted on Niger seed agar medium with or without uracil (20 lM) and incubated at 30 C for
up to 96 h. Melanin production is represented by a dark brown pigment. Strains used are: wild type (KN99a), ura4::NeoR (FGC003), reconstituted strain ura4 + URA4
(FGC003R1), ura5 mutant and H86 (laccase-deﬁcient mutant) as negative control. (B) Capsule production detected by India ink staining and DIC microscopy in bright ﬁeld,
immune ﬂuorescence microscopy and both images merged. Medium used was CO2-independent medium with and without uracil. Image captures were performed after 24 h
post-capsule induction. Strains used: wild type (KN99a), ura4::NeoR (FGC003), reconstituted strain ura4D + URA4 (FGC003R1). Refer to material and methods for
immunoﬂuorescence details. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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C. neoformans intracellular survival.
3.8. URA4 gene is essential for in vivo survival
We compared the relative virulence of the wild type, ura4, and
ura4 + URA4 reconstituted strains in a murine inhalational modelof cryptococcosis (Cox et al., 2000). As presented in Fig. 5, infections
with the wild type and reconstituted strains resulted in an average
survival of 17.5 (±1.87) and 17.5 (±1.58) days post-infection,
respectively. On the contrary, the ura4mutant strain-infected mice
survived until the end of the experiment (40 days post-infection).
Lungs from two of the surviving mice were harvested and homog-
enized, followed by serial dilution and quantitative cultures. Even
Fig. 4. The ura4mutation renders cells susceptible to multi stress. Dilutions (104 to
1 cell) of wild type (KN99a), ura4::NeoR (FGC003) and reconstituted strain
ura4D + URA4 (FGC003R1) were spotted on (A) YPD, YPD + 0.5% Congo Red and
YPD + 0.5% Congo Red + uracil and (B) YPD, YPD + 0.75 M NaCl, YPD + 0.75 M KCl
and YPD (pH 8.0). Plates were incubated at 30 C from 48 to 72 h.
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viable yeast cells in their lungs (2.04  105 ± 5.6  103 CFU/mg).
Also, we checked whether the ura4mutant would display atten-
uated virulence at the permissive growth temperature (30 C) in a
G. mellonella killing assay. The wild-type strain and the reconsti-
tuted (ura4 + URA4) strains resulted in killing of all Galleria larvae
at 3 and 5 days, respectively. In contrast, infection with the ura4
mutant strain did not result in host killing in this assay, statistically
similar to PBS treatment (p < 0.05 between mutant and wild-type)
(Fig. 6). Therefore, we conclude that the ura4mutant is attenuated
for virulence at both permissive and restrictive temperatures for its
growth.3.9. Pyrimidine de novo and salvage pathway genes respond to high
temperature growth
We have demonstrated that several of the major virulence phe-
notypes are affected by both ura4 and ura5 mutations. Therefore,
we analyzed the transcriptional pattern of the genes involved in
the pyrimidine biosynthetic and salvage pathways by real time
PCR in complex medium (YPD) and synthetic medium (YNB) at
30 C and 37 C. Figs. 7A and 8A show that the expression pattern
for genes in both pathways does not change substantially in rich
medium (YPD) regardless of the temperature. All the genes tested,
in both de novo and salvage pathways, were induced when incu-
bated in YNB medium not supplemented with uracil at 37 C com-
pared to 30 C (Figs. 7B and 8B, respectively). The highest levels of
induction in these experiments are for URA4, URA2 and URA1,
which have 4.6-, 6.5- and 2.9-fold increases in expression after
2 h at 37 C in YNB. In the salvage pathway there is a 5-fold
increase in CDD1 expression at 37 C in YNB and a 2-fold increase
for URK1 and URH1. These results indicate that there is increased
transcript abundance for multiple genes in the pyrimidine de novo
biosynthesis and also the salvage pathway during growth at
human physiological temperature in poor nutritional condition,
which is a situation likely encountered during the host infection.
We also tested the role of the ura4 mutation on the transcrip-
tional induction of other genes in these pathways. URA2 and
URA3 are 2.5- and 1.8-fold induced, respectively, in complex med-
ium (YPD) at 37 C in the ura4mutant compared to YPD medium atFig. 5. Virulence test. Groups of ten 4- to 6-week-old 57BL/6 mice were infected by
nasal inhalation with wild type (KN99a), ura4::NeoR (FGC003) and reconstituted
strain ura4D::URA4 (FGC003R1). Survival was followed during the course of the
infection. p values were <0.001 for the comparisons between ura4::NeoR (FGC003),
and wild type and ura4D + URA4 (FGC003R1). Five mice were inoculated with the
wild type (KN99a).
Fig. 6. C. neoformans ura4 mutant is avirulent in an invertebrate infection model at
30 C. Galleria mellonella larvae were inoculated with either the wild type (KN99a),
ura4::NeoR (FGC003) or reconstituted strain ura4D + URA4 (FGC003R1). The
infected larvae were monitored for survival.
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expression for URA1, URA5 and URA6 (Fig. 7C).
A pronounced shift in expression pattern of the genes in the de
novo biosynthetic pathway was observed when the ura4 mutant
strain was cultivated in synthetic medium (YNB) at the restrictive
temperature (37 C): all 5 genes tested are down-regulated at 37 C
(Fig. 7D). URA1, URA2 and URA6 had a 20% reduction of their
expression on YNB at 37 C compared to 30 C. URA3 and URA5
genes also had their transcription pattern dramatically repressed
(40% and 20%) compared to YNB at 30 C (Fig. 8D).Fig. 7. Real time PCR. Expression pattern of the pyrimidine de novo pathway genes URA1,
synthetic medium YNB (no uracil added) and the mutant strain ura4 cultivated in (C) ricComparatively, all 5 genes (URA1, URA2, URA3, URA5 and URA6)
were induced in the wild type strain incubated in YNB at 37 C
(2.9-, 4.6-, 1.8-, 2.0- and 2.8-fold respectively, Fig. 7B). These data
suggest that the dihydroorotase gene may play a regulatory role
in the pyrimidine biosynthetic pathway where the lack of its func-
tion impairs the transcriptional response necessary during heat
stress. No signiﬁcant alterations in transcript abundance were
noted for the genes in the uracil salvage pathway in the ura4
mutant background, at either temperature, or in either rich or poor
growth media (Fig. 8C and D). Taken together these observations
suggest that dihydroorotase may act as a regulatory point in both
the de novo and the salvage pathways, being necessary to respond
to the stresses encountered at high temperatures with nutrient
depletion.4. Discussion
Insertional mutagenesis mediated by A. tumefaciens in C. neofor-
mans has been a useful tool for gene function discovery and analysis
(Idnurm et al., 2004; Idnurm and Heitman, 2005; Walton et al.,
2005, 2006; Feretzaki and Heitman, 2013; Lee et al., 2013). In this
paper, this technique was employed to identify genes involved in
high temperature growth, an important virulence factor for this
yeast. Among the transformants unable to grow at high tempera-
ture, we identiﬁed one that has a truncated copy of the URA4 gene.
This enzyme, which is involved in the third step on the pyrimidine
pathway, catalyzes the conversion of carbamoyl-L-aspartate to
dihydroorotate. The role of the C. neoformans pyrimidine biosyn-
thetic pathway in high temperature growth was conﬁrmed with
independently generated ura4mutants, as well as by documenting
temperature-restricted growth of the ura5 mutant strain, with a
defect in a separate gene in this pathway. Transcriptional proﬁling2, 3, 4, 5 and 6 in the wild type strain KN99 cultivated in (A) rich medium YPD and (B)
h medium YPD and (D) synthetic medium YNB (no uracil added) at 30 C and 37 C.
Fig. 8. Real time PCR. Expression pattern of the pyrimidine salvage pathway genes CDD1, URK1, URH1 in the wild type strain KN99 cultivated in (A) rich medium YPD and (B)
synthetic medium YNB (no uracil added) and the mutant strain ura4 cultivated in (C) rich medium YPD and (D) synthetic medium YNB (no uracil added) at 30 C and 37 C.
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and heat stress, since both biosynthetic and salvage pathways are
highly induced at 37 C. Another relevant ﬁnding was the role of
this pathway in general stress tolerance.Moreover, strainswith loss
of pyrimidine biosynthesis had attenuated virulence.
Previously, C. albicans URA3 has been used as a selectablemarker
(URA-blaster), generating over time a large mutant collections
(Fonzi and Irwin, 1993). Brand et al. (2004) reported a genome posi-
tion effect upon URA3 expression: lower URA3 transcriptional levels
determined by location correlated with attenuated virulence. In
C. neoformans the URA5 gene was used to assist molecular genetic
manipulation of this fungus as a selectable marker for transforma-
tion (Edman and Kwon-Chung, 1990; Varma et al., 1992). The
in vitro phenotypes of this mutant strain were not explored in
depth. The ura5 mutant was noted to be highly attenuated in a
murine model of systemic cryptococcosis, although this strain
eventually caused lethal disease in mice (Varma et al., 1992). This
ﬁnding is similar to the studies presented here: although the ura4
mutant caused no mortality after 40 days of infection, the strain
was still viable and recoverable from infected tissue at the end of
the experiment.
In similar studies, an adenine auxotrophic mutant was recov-
ered from a patient with systemic cryptococcosis (Schiappa et al.,
2002). Prior studies had suggested that defects in adenine biosyn-
thesis resulted in profound virulence defects in a rabbit model of
cryptococcal meningitis (Perfect et al., 1993). It is possible that dif-
ferent microenvironments in the host may offer different nutrient
availability for these strains. Therefore, an adenine auxotrophic
strain may be able to grow in the bone marrow, a tissue in which
adenine is not predicted to be a limiting nutrient given the high cell
turnover at this site. However, the same auxotrophic strain may be
unable to grow in cerebral spinal ﬂuid, which ismore nutrient-poor.
Other studies have suggested that the analysis of metabolic
pathways has the potential to identify targets for novel therapeutic
interventions for cryptococcal disease. C. neoformansmutants withdefects in methionine, threonine, isoleucine, valine and lysine bio-
synthesis display reduced growth rates, high temperature growth
defects, sensitivity to the inhibitory effects of antifungal drugs
and reduced virulence (Yang et al., 2002; Pascon et al., 2004;
Kingsbury et al., 2004; Kingsbury et al., 2004a; Kingsbury and
McCusker, 2008; Kingsbury and McCusker, 2010; Kingsbury and
McCusker, 2010a; Kingsbury and McCusker, 2010b). Therefore,
defects in metabolic pathways may offer more attenuation in sur-
vival than merely inducing speciﬁc nutritional auxotrophies.
Recently, the purine biosynthetic pathway in C. neoformanswas
studied as a novel target for antifungal intervention (Morrow et al.,
2012). Defects in de novo purine biosynthesis, and not purine sal-
vage, resulted in strains with growth defects and reduced virulence.
Moreover, fungal-speciﬁc features were identiﬁed in the predicted
structure of the inosine monophosphate dehydrogenase enzyme
involved in guanine nucleotide synthesis. Together, these studies
suggest that nucleic acid synthesis pathways offer potential, unex-
plored targets for intervention in treating fungal diseases.
Reduced growth caused by dihydroorotase defects have been
reported in other organisms. For example, in Salmonella typhimuri-
um lack of pyrC (URA4 homolog) prevents the conversion of carbam-
oyl aspartate to dihydroorotate, leading to the accumulation of
toxic intermediaries, which may cause growth reduction
(Turnbough and Bochner, 1985). In S. cerevisiae the ura4 mutant
has reduced vegetative growth at 30 C (Yoshikawa et al., 2011).
In a clinical isolate of S. cerevisiae, lack of the Ura3 protein led to a
reduced rate of growth for themutant and also renders a strainwith
attenuated virulence in a murine model of infection (Goldstein
and McCusker, 2001). In the parasite Trypanosoma brucei it was
found that alterations in pyrimidine biosynthesis yielded strains
with low infectivity in animal model (Ali et al., 2013). Also in T. gon-
dii, strains with a uracil auxotrophy elicit protective immunity to
subsequent infection (Fox and Bzik, 2010). Moreover, Hegewald
et al. (2013) demonstrated that dihydroorotate dehydrogenase
(URA1) is a relevant drug target for 1-hydroxyquinolones in
22 F.A. de Gontijo et al. / Fungal Genetics and Biology 70 (2014) 12–23T. gondii. Taken together, this work implicates the importance of the
pyrimidine biosynthetic pathways in the virulence of multiple
microbial pathogens, suggesting that inhibitors of gene products
within this pathway could help to treat diverse infections, perhaps
in association with other therapeutic drugs. We showed that lack of
functional Ura4 in C. neoformans affects other virulence factors and
reduced stress response; however, at this point our results do not
allow us to explain the mechanism of this interference, and new
experiments such as global gene expression under pyrimidine
depletion could be performed to shed some light on this issue.
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